BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

PharmAbcine Receives Safety Approval for 4mg Dose in Phase 1 Trial of PMC-403, Paving the Way for Multiple Ascending Dose Study

Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascending dose 4 mg cohort. ...

October 15, 2024 | News

CooperVision Announces 4th Asia-Pacific Myopia Management Symposium in Seoul to Tackle Rising Myopia in Children

CooperVision, a global leader in myopia management, is proud to announce the 4th Asia-Pacific Myopia Management Symposium (APMMS) will take ...

October 15, 2024 | News

Samsung Biologics Introduces S-HiCon™ Platform to Optimize High-Concentration Drug Formulations

S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated...

October 15, 2024 | News

Werfen Becomes First European Partner in Seegene's Technology-Sharing Initiative, Co-Establishing NewCo in Spain

Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technol...

October 09, 2024 | News

SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development

SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bio...

October 08, 2024 | News

ABL Bio Partners with MSD to Evaluate ABL103 and KEYTRUDA® Combo in Advanced Solid Tumor Clinical Trial

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a clinical trial collaboration ...

October 07, 2024 | News

Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies

First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...

October 03, 2024 | News

SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry

- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...

October 02, 2024 | News

Cytiva Launches State-of-the-Art Innovation Hub in South Korea, Paving the Way for Biopharma Breakthroughs in APAC

The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility together with a customer experience lab. Operations of the...

October 01, 2024 | News

SK Pharmteco Invests $260 Million in New Sejong Facility to Boost Small Molecule and Peptide Production

- Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong - More than 300 new employees to be hired for the anticipated 2026 ...

September 30, 2024 | News

Samsung Biologics Introduces Advanced Development Platforms to Boost Therapeutic Efficacy

Samsung Biologics showcases new innovative development platforms – S-AfuCHOTM and S-OptiChargeTM – at BioProcess International...

September 26, 2024 | News

Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®

Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...

September 18, 2024 | News

Hyundai Bioscience Announces XAFTY®: A Breakthrough Broad-Spectrum Antiviral for COVID-19, Mpox, and Dengue

Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadel...

September 12, 2024 | News

GC Cell Partners with Indonesia’s Bifarma in Major Technology Transfer for Immuncell-LC Cancer Therapy

GC Cell, a leading innovator in cell therapy, has officially announced the execution of a landmark 'Technology Transfer and License Agreement' with PT Bifa...

September 11, 2024 | News

Stay Connected